BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 10, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 22, 2010
View Archived Issues
Psychiatric Drug Safety Test: New Wave in Predictive Push
Read More
Pharma, Generics Firms See More Green on the Other Side
Cephalon Inc.'s recent $590 million purchase of Swiss generics player Mepha AG was intended to create a balanced portfolio of branded products and generics.
Read More
Money Raised By Biotech in 2010
Read More
The Mod 'Quad': Gilead's Pill Could Plant Next Flag in HIV
Read More
Money Raised Year to Date
Read More
Week in Review
Read More
Word on the Street
Read More
Week in Washington
Read More
Biotechnology Company Deals With Other Biotechnology Companies: Dec. 1, 2009 - Feb. 18, 2010
Read More
Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Dec. 1, 2009 - Feb. 18, 2010
Read More
Biotech-Biotech Collaborations: Modified Agreements: Dec. 1, 2009 - Feb. 18, 2010
Read More
Biotech Collaborations And Other Actions In Agriculture And Animals: Jan. 1 - Dec. 31, 2009
Read More
Stock Gainers and Losers For The Week
Read More
BioWorld Stock Report For Public Biotechnology Companies
Read More
